Cerapedics
Westminster, US · Delaware corporation · 1 known investors
Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
Founders & leadership
BP
Britt PearsonExecutive
JM
Jeff MarxExecutive
GK
Glen KashubaExecutive
JC
Jerome ConnorExecutive
CS
Chen SchorNamed on SEC filing
AJ
Andrew J TofeNamed on SEC filing
KS
Ken S. AbramowitzNamed on SEC filing
AH
Andrew HandwerkerNamed on SEC filing
LH
Leonard HabasNamed on SEC filing
PJ
Paul J. MrazNamed on SEC filing
Board
JS
CK
Investors · 1
Reported raises · per SEC filings
Form D private placements$65M disclosed across 5 rounds · 2012–2022
▶$25MraisedMar 2022 · 6 investors · BiotechnologyRule 506(b)
▶$25MraisedMar 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nael KassarDirector
- Glen KashubaExecutive Officer, Director
- Ken AbramowitzDirector
- Antony KoblishDirector
- John TattoryExecutive Officer
- Greg GarfieldDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Jeffrey G. MarxExecutive Officer
- Tyrell RiversDirector
- Valeska SchroederDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJul 2018 · 2 investors · BiotechnologyRule 506(b)
▶$22MraisedJul 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glen KashubaExecutive Officer, Director
- Chau KhuongDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Antony KoblishDirector
- Drew TrivisonnoExecutive Officer
- Tyrell RiversDirector
- Jeffrey G. MarxExecutive Officer
- Ken AbramowitzDirector
- Offering amount
- $22M
- Amount sold
- $22M
- Sales commissions
- $1.2M
- Placement agents
- Easterly Securities LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedSep 2016 · 8 investors · BiotechnologyRule 506(b)
▶$11MraisedSep 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noah KroloffDirector
- Antony KoblishDirector
- Jonathan SilversteinDirector
- Britt PearsonExecutive Officer
- Andrew J. TofeDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Jerome ConnorExecutive Officer
- Chau KhuongDirector
- Samuel S. WuDirector
- Offering amount
- $14M
- Amount sold
- $11M
- Sales commissions
- $500K
- Placement agents
- Leerink Partners LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedFeb 2015 · 5 investors · BiotechnologyRule 506(b)
▶$4MraisedFeb 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. TofeDirector
- Britt PearsonExecutive Officer
- Jonathan SilversteinDirector
- Chau KhuongDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Samuel S. WuDirector
- Jerome ConnorExecutive Officer
- Noah KroloffDirector
- Antony KoblishDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedFeb 2012 · 3 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2012 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SilversteinDirector
- Chen SchorDirector
- Andrew J TofeDirector
- Ken S. AbramowitzDirector
- Andrew HandwerkerExecutive Officer
- Leonard HabasDirector
- Paul J. MrazExecutive Officer, Director
- Chau KhuongDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Rf Surgical20 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Nuvasive14 shared keywordsNuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.
Genhealth13 shared keywordsGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Globus Medical10 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Companies competing with Cerapedics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cerapedics do?
- Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
- Who are Cerapedics's investors?
- Cerapedics's investors include OrbiMed.
- How much funding has Cerapedics raised?
- Cerapedics has disclosed $65M raised across 5 rounds.
- Where is Cerapedics headquartered?
- Cerapedics is headquartered in Westminster, US.